Zojwalla Naseem
- SEC CIK
- 0001905871
In the past year, 1 open-market sale filing worth $7.53M and no purchases.
Current role at each company
- OLMA Olema Pharmaceuticals, Inc.CHIEF MEDICAL OFFICERas of Feb 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.53M
- 1 filing
- Net
- −$7.53M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Zojwalla Naseem as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 (view filing) | Dec 19-23 | 4 days | Zojwalla NaseemChief Medical Officer | SSale | −269.5K | $27.94 | −$7.53M | −98.4%4.49K after | 4 lots |
| Dec 11, 2024 (view filing) | Dec 10-11 | 1 day | Zojwalla NaseemCHIEF MEDICAL OFFICER | SSale | −27.8K | $9.01 | −$250.5K | −19.4%115.5K after | 3 lots |
| Nov 22, 2023 (view filing) | Nov 21-22 | 1 day | Zojwalla NaseemCHIEF MEDICAL OFFICER | SSale | −14.6K | $14.38 | −$209.3K | −32.2%30.7K after | 3 lots |